ARCHIVES

PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval.

This article is from The Cancer Letter archive.

Vol. 34 No. 08 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Breast Implants Lessen Ability Of Mammograms To Find Cancer

February 27, 2004

Funding Opportunity.

July 12, 2002

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 5, 1974

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

Cancer Policy: New Cancer Board to Take A Year to Conduct First Study

April 18, 1997